ASCENTAGE PHARMA GR-ADR (AAPG) Stock Earnings & Estimates
NASDAQ:AAPG - ADR
41.82 USD
-0.65 (-1.53%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 209.711M 651.38% | 221.984M 5.85% | 980.65M 341.77% | 566.1M -42.27% | 2.761B 387.72% | 1.774B -35.75% | 2.27B 27.96% | 2.952B 30.04% | 2.751B -6.81% | 3.244B 17.92% | 3.745B 15.44% | |
| EBITDA YoY % growth | -791.464M 8.49% | -796.726M -0.66% | -281.002M 64.73% | -972.446M -246.06% | 961.04M 198.83% | 56.1K -99.99% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -852.935M 4.51% | -874.038M -2.47% | -374.171M 57.19% | -1.008B -169.51% | 922.46M 191.48% | -229.101M -124.84% | 180.45M 178.76% | 661.87M 266.79% | 731.96M 10.59% | 1.264B 72.69% | 1.763B 39.48% | |
| Operating Margin | -406.72% | -393.74% | -38.16% | -178.14% | 33.41% | -12.91% | 7.95% | 22.42% | 26.61% | 38.96% | 47.08% | |
| EPS YoY % growth | N/A -6.38% | N/A 12.05% | N/A 61.78% | -9.89 -168.02% | 9.03 191.29% | -1.07 -111.86% | N/A | N/A | N/A | N/A | N/A |
All data in CNY
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in CNY
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 156.904M 97.90% | % | ||
| Q2 2024 Q2Q % growth | 823.746M 477.25% | % | ||
| Q4 2023 Q2Q % growth | 79.283M -30.42% | % | ||
| Q2 2023 Q2Q % growth | 142.701M 49.01% | % | ||
| Q4 2022 Q2Q % growth | 113.948M 662.45% | % | ||
| Q2 2022 Q2Q % growth | 95.763M 638.63% | % | ||
| Q4 2021 Q2Q % growth | 14.945M 51.93% | % | ||
| Q2 2021 Q2Q % growth | 12.965M 396.17% | % | ||
| Q4 2020 Q2Q % growth | 9.837M -19.34% | % | ||
| Q2 2020 Q2Q % growth | 2.613M 12.78% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 5.2% | 11.17% |
| Revenue | N/A | N/A | 4.52% | 6.82% |